Apellis Pharmaceuticals shares owned by Capital Impact Advisors
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Capital Impact Advisors
from 13F filings
Historical chart of Capital Impact Advisors investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Capital Impact Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $508k | 5.6k | 91.10 |
| 2023-03-31 | $919k | 14k | 65.96 |
| 2022-12-31 | $722k | 14k | 51.71 |
| 2022-09-30 | $604k | 14k | 43.27 |
| 2022-06-30 | $601k | 13k | 45.19 |